Quantinno Capital Management LP Boosts Stock Position in Corteva, Inc. $CTVA

Quantinno Capital Management LP lifted its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 52.7% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 444,587 shares of the company’s stock after buying an additional 153,499 shares during the period. Quantinno Capital Management LP’s holdings in Corteva were worth $37,216,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CTVA. Brighton Jones LLC increased its holdings in Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after acquiring an additional 11,760 shares in the last quarter. Woodline Partners LP lifted its holdings in Corteva by 40.3% during the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in Corteva by 62.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after purchasing an additional 980 shares in the last quarter. Cresset Asset Management LLC grew its position in shares of Corteva by 2.6% in the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock valued at $526,000 after purchasing an additional 181 shares during the period. Finally, Jump Financial LLC acquired a new stake in shares of Corteva in the second quarter valued at about $1,464,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

Shares of NYSE CTVA opened at $89.39 on Friday. The firm has a 50-day simple moving average of $82.16 and a 200-day simple moving average of $79.55. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $59.79 billion, a price-to-earnings ratio of 52.58, a price-to-earnings-growth ratio of 2.74 and a beta of 0.56. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $90.97.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same period in the previous year, the business posted $2.20 earnings per share. Corteva’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts predict that Corteva, Inc. will post 3.76 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, September 1st. Corteva’s payout ratio is currently 42.35%.

Wall Street Analyst Weigh In

CTVA has been the subject of several research analyst reports. Morgan Stanley upped their price target on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. Bank of America lifted their price objective on Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a report on Monday, July 20th. Zacks Research upgraded Corteva from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. Citigroup increased their target price on Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Finally, BNP Paribas Exane raised their target price on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $90.19.

Corteva News Summary

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Quarterly earnings exceeded expectations: Corteva reported second-quarter EPS of $2.30, above the $2.24 consensus estimate and up from $2.20 a year earlier. Corteva Q2 Earnings Beat Estimates
• Positive Sentiment: Full-year outlook was raised: Management increased its 2026 EPS guidance to $3.60-$3.80, reflecting strong first-half performance, cost controls and growth from strategic platforms. The midpoint is broadly consistent with analyst expectations. Corteva Delivers Strong First Half and Raises Outlook
• Positive Sentiment: Growth initiatives remain supportive: Demand for newer seed germplasm, trait technologies and crop-protection products, along with licensing growth and operational improvements, helped offset competitive pricing pressure. Corteva also remains on schedule for the planned October 1 Vylor spin-off. Why Corteva’s Seed and Crop Protection Engines Matter
• Neutral Sentiment: Separation could reshape the investment story: Corteva’s innovation pipeline, including crop-protection products and royalty opportunities, may support future growth after the planned business split, although the benefits will depend on execution. Corteva’s Innovation Pipeline
• Negative Sentiment: Revenue missed expectations: Second-quarter revenue was $6.38 billion, below the $6.60 billion analyst estimate, and declined 1.2% year over year. Competitive pricing remains a concern. Corteva Earnings Press Release
• Negative Sentiment: Valuation and execution risks are elevated: After a powerful rally, CTVA trades near its 52-week high at a premium earnings multiple. Investors may remain cautious about separation costs, execution risk and whether growth can justify the valuation. Is CTVA Stock Worth Buying After Its Rally?

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.